Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TEAD1 | P28347 | 1/20 | 0.56 |
| ▸ | TEAD3 | Q99594 | 1/20 | 0.56 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8081852 | 0.91 | LTA4H (0.50) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL5722056 | 0.91 | TEAD1 (0.50) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL5722059 | 0.91 | TEAD1 (0.54) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL8284721 | 0.91 | TAAR1 (0.52) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL5722054 | 0.91 | TEAD1 (0.54) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL9349642 | 0.91 | TEAD1 (0.50) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL8286318 | 0.91 | TAAR1 (0.57) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL8529857 | 0.91 | LTA4H (0.50) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL9349635 | 0.91 | TEAD1 (0.50) | TEAD1TEAD3KCNA3NFE2L2TAAR1 | |
| SCHEMBL13103169 | 0.90 | NFE2L2 (0.69) | TEAD1TEAD3KCNA3NFE2L2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1505945-B1 | SUBSTITUTED CYCLOALKYL P1' HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2008-11-05 | — | — | EP | disclosed |